Estonia - estoński - Ravimiamet

berlin-chemie ag - metformiin - toimeainet prolongeeritult vabastav tablett - 750mg 90tk; 750mg 60tk; 750mg 30tk; 750mg 120tk

Unia Europejska - estoński - EMA (European Medicines Agency)

accord healthcare s.l.u. - sitagliptin hydrochloride - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Unia Europejska - estoński - EMA (European Medicines Agency)

astrazeneca ab - metformiin vesinikkloriid, saxagliptin, dapagliflozin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - qtrilmet on näidustatud täiskasvanutel vanuses 18 aastat ja vanemad, tüüp 2 diabeet:parandada glycaemic kontrollida, kui metformiin koos või ilma sulphonylurea (su) ja kas saxagliptin või dapagliflozin ei anna adekvaatset kontrolli glycaemic. kui juba ravitakse metformiin ja saxagliptin ja dapagliflozin.

Estonia - estoński - Ravimiamet

zentiva k.s. - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 30tk; 1000mg+50mg 10tk; 1000mg+50mg 60tk

Estonia - estoński - Ravimiamet

zentiva k.s. - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 180tk; 850mg+50mg 10tk; 850mg+50mg 60tk

Estonia - estoński - Ravimiamet

g.l. pharma gmbh - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 30tk; 850mg+50mg 200tk; 850mg+50mg 60tk; 850mg+50mg 56tk; 850mg+50mg 196tk

Estonia - estoński - Ravimiamet

g.l. pharma gmbh - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 56tk; 1000mg+50mg 60tk; 1000mg+50mg 28tk; 1000mg+50mg 196tk; 1000mg+50mg 200tk

Estonia - estoński - Ravimiamet

medochemie limited - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 60tk; 850mg+50mg 180tk; 850mg+50mg 30tk; 850mg+50mg 10tk

Estonia - estoński - Ravimiamet

berlin-chemie ag - metformiin - õhukese polümeerikattega tablett - 500mg 120tk; 500mg 60tk

Estonia - estoński - Ravimiamet

sandoz pharmaceuticals d.d. - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 30tk